OCRELIZUMAB
ocrelizumab 300 mg/10 mL injection, 10 mL vial
OCRELIZUMAB (11242Q)
11242Q
Manner of administration:Injection
Restriction (Streamlined authority code: 7699)
Indication: Multiple sclerosis
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 7386)
Indication: Multiple sclerosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 0 | DPMQ: $16,656.36 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ocrevus | |||||